Paradigm Biopharmaceuticals Ltd
ASX:PAR
Paradigm Biopharmaceuticals Ltd
ASX:PAR
Price:
0.28 AUD
-1.75%
Market Closed
Updated:
May 17, 2024
Paradigm Biopharmaceuticals Ltd
Pre-Tax Income
|
Paradigm Biopharmaceuticals Ltd
Pre-Tax Income Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Paradigm Biopharmaceuticals Ltd
ASX:PAR
|
Pre-Tax Income
-AU$69m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
N/A
|
|
|
Immutep Ltd
ASX:IMM
|
Pre-Tax Income
-AU$40.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-12%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Pre-Tax Income
-$73.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Pre-Tax Income
$3.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Pre-Tax Income
AU$45.8m
|
CAGR 3-Years
40%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Pre-Tax Income
AU$3.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Paradigm Biopharmaceuticals Ltd's Pre-Tax Income?
Pre-Tax Income
-69m
AUD
-69m
AUD
Based on the financial report for Dec 31, 2023, Paradigm Biopharmaceuticals Ltd's Pre-Tax Income amounts to -69m AUD.
What is Paradigm Biopharmaceuticals Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-58%
-58%
Over the last year, the Pre-Tax Income growth was -56%. The average annual Pre-Tax Income growth rates for Paradigm Biopharmaceuticals Ltd have been -35% over the past three years , -58% over the past five years .
You don't have any saved screeners yet
